AstraZeneca Pharma India Ltd Q2 Results
- BSE: 506820
- NSE: ASTRAZEN
- ISIN: INE203A01020
- Sector: Biotechnology & Drugs
BSE
7,753.70
-37.90 (-0.49%)
-37.90 (-0.49%)Volume158.00
Updated: Fri 14 Aug, 2026 | 15:51:57
NSE
7,730-62.50 (-0.80%)
-62.50 (-0.80%)Volume5.62 K
Updated: Fri 14 Aug, 2026 | 15:29:42
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - AstraZeneca Pharma India Ltd Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 26 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 491.77 | 639.32 | 6.41% |
| Depreciation/ Amortization | 2.57 | 5.23 | -84.49% |
| Operating Income | 67.32 | 43.47 | 4.89% |
| Net Income | 54.22 | 37.93 | -2.88% |
| Other Operating Expenses Total | 65.51 | 74.13 | 7.20% |
| Net Income Before Taxes | 72.82 | 50.75 | -2.52% |
| Total Revenue | 559.09 | 682.79 | 6.23% |
| Selling/ General/ Admin Expenses Total | 93.91 | 112.51 | 5.90% |
| Diluted Normalized EPS | 23.27 | 15.24 | 3.69% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.